Aquestive Therapeutics (AQST) Interest Coverage Ratio Growth (3y) (2020 - 2026)
Aquestive Therapeutics (AQST) Interest Coverage Ratio Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.69 Bn | 87.82 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.84 Bn | 32.10 Bn | 1.97 Bn | - |
| 3 | Zoetis | 32.67 Bn | 30.73 Bn | 1.62 Bn | 17.14% |
| 4 | Takeda Pharmaceutical | 27.69 Bn | 23.63 Bn | 4.39 Bn | 0.23% |
| 5 | United Therapeutics | 23.12 Bn | 20.97 Bn | 648.10 Mn | -28.01% |
| 6 | RedHill Biopharma | 21.80 Bn | 21.80 Bn | - | - |
| 7 | Viatris | 20.24 Bn | 18.44 Bn | 1.16 Bn | -32.31% |
| 8 | Neurocrine Biosciences | 17.83 Bn | 16.51 Bn | 800.70 Mn | 26.99% |
| 9 | Elanco Animal Health | 12.64 Bn | 12.22 Bn | 785.00 Mn | 41.72% |
| 10 | Aquestive Therapeutics | 459.17 Mn | 459.17 Mn | 13.47 Mn | -10.61% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10.61% |
| Dec 31, 2025 | 58.47% |
| Sep 30, 2025 | -7.12% |
| Jun 30, 2025 | 30.65% |
| Mar 31, 2025 | 7.52% |
| Dec 31, 2024 | 31.44% |
| Sep 30, 2024 | 22.96% |
| Jun 30, 2024 | 26.07% |
| Mar 31, 2024 | 33.38% |
| Dec 31, 2023 | 26.95% |
| Sep 30, 2023 | 52.75% |
| Jun 30, 2023 | -67.88% |
| Mar 31, 2023 | 35.07% |
| Dec 31, 2022 | 5.83% |
| Sep 30, 2022 | 8.89% |
| Jun 30, 2022 | 24.09% |
| Mar 31, 2022 | 19.75% |
| Dec 31, 2021 | 49.34% |
| Sep 30, 2021 | 12.39% |
| Jun 30, 2021 | 45.68% |